184 related articles for article (PubMed ID: 20233721)
21. Dephosphorylation of Carma1 by PP2A negatively regulates T-cell activation.
Eitelhuber AC; Warth S; Schimmack G; Düwel M; Hadian K; Demski K; Beisker W; Shinohara H; Kurosaki T; Heissmeyer V; Krappmann D
EMBO J; 2011 Feb; 30(3):594-605. PubMed ID: 21157432
[TBL] [Abstract][Full Text] [Related]
22. Nuclear factor-kappaB modulates regulatory T cell development by directly regulating expression of Foxp3 transcription factor.
Long M; Park SG; Strickland I; Hayden MS; Ghosh S
Immunity; 2009 Dec; 31(6):921-31. PubMed ID: 20064449
[TBL] [Abstract][Full Text] [Related]
23. CARMA1 coiled-coil domain is involved in the oligomerization and subcellular localization of CARMA1 and is required for T cell receptor-induced NF-kappaB activation.
Tanner MJ; Hanel W; Gaffen SL; Lin X
J Biol Chem; 2007 Jun; 282(23):17141-7. PubMed ID: 17428801
[TBL] [Abstract][Full Text] [Related]
24. Differential requirement for CARMA1 in agonist-selected T-cell development.
Medoff BD; Sandall BP; Landry A; Nagahama K; Mizoguchi A; Luster AD; Xavier RJ
Eur J Immunol; 2009 Jan; 39(1):78-84. PubMed ID: 19130560
[TBL] [Abstract][Full Text] [Related]
25. CARD11 regulates the thymic Treg development in an NF-κB-independent manner.
Hu Y; Han L; Xu W; Li T; Zhao Q; Lu W; Sun J; Wang Y
Front Immunol; 2024; 15():1364957. PubMed ID: 38650932
[TBL] [Abstract][Full Text] [Related]
26. CD28 stimulation triggers NF-kappaB activation through the CARMA1-PKCtheta-Grb2/Gads axis.
Takeda K; Harada Y; Watanabe R; Inutake Y; Ogawa S; Onuki K; Kagaya S; Tanabe K; Kishimoto H; Abe R
Int Immunol; 2008 Dec; 20(12):1507-15. PubMed ID: 18829987
[TBL] [Abstract][Full Text] [Related]
27. Proteasome inhibitors impair RANKL-induced NF-kappaB activity in osteoclast-like cells via disruption of p62, TRAF6, CYLD, and IkappaBalpha signaling cascades.
Ang E; Pavlos NJ; Rea SL; Qi M; Chai T; Walsh JP; Ratajczak T; Zheng MH; Xu J
J Cell Physiol; 2009 Aug; 220(2):450-9. PubMed ID: 19365810
[TBL] [Abstract][Full Text] [Related]
28. CYLD Deubiquitinase Negatively Regulates High Glucose-Induced NF-
Li Y; Huang W; Xu Y; Zhou L; Liang Y; Gao C; Long Y; Xu Y
Biomed Res Int; 2017; 2017():3982906. PubMed ID: 29259980
[TBL] [Abstract][Full Text] [Related]
29. Characteristics of CARMA1-BCL10-MALT1-A20-NF-κB expression in T cell-acute lymphocytic leukemia.
Ma Y; Liao Z; Xu Y; Zhong Z; Wang X; Zhang F; Chen S; Yang L; Luo G; Huang X; Huang S; Wu X; Li Y
Eur J Med Res; 2014 Nov; 19(1):62. PubMed ID: 25384343
[TBL] [Abstract][Full Text] [Related]
30. Ca2+/calmodulin-dependent protein kinase II is a modulator of CARMA1-mediated NF-kappaB activation.
Ishiguro K; Green T; Rapley J; Wachtel H; Giallourakis C; Landry A; Cao Z; Lu N; Takafumi A; Goto H; Daly MJ; Xavier RJ
Mol Cell Biol; 2006 Jul; 26(14):5497-508. PubMed ID: 16809782
[TBL] [Abstract][Full Text] [Related]
31. Potential role of CARMA1 in CD40-induced splenic B cell proliferation and marginal zone B cell maturation.
Pappu BP; Lin X
Eur J Immunol; 2006 Nov; 36(11):3033-43. PubMed ID: 17048267
[TBL] [Abstract][Full Text] [Related]
32. CARMA1-mediated NF-kappaB and JNK activation in lymphocytes.
Blonska M; Lin X
Immunol Rev; 2009 Mar; 228(1):199-211. PubMed ID: 19290929
[TBL] [Abstract][Full Text] [Related]
33. CARMA1 is required for Akt-mediated NF-kappaB activation in T cells.
Narayan P; Holt B; Tosti R; Kane LP
Mol Cell Biol; 2006 Mar; 26(6):2327-36. PubMed ID: 16508008
[TBL] [Abstract][Full Text] [Related]
34. Phosphorylation of the CARMA1 linker controls NF-kappaB activation.
Sommer K; Guo B; Pomerantz JL; Bandaranayake AD; Moreno-García ME; Ovechkina YL; Rawlings DJ
Immunity; 2005 Dec; 23(6):561-74. PubMed ID: 16356855
[TBL] [Abstract][Full Text] [Related]
35. Phosphorylation of CARMA1 plays a critical role in T Cell receptor-mediated NF-kappaB activation.
Matsumoto R; Wang D; Blonska M; Li H; Kobayashi M; Pappu B; Chen Y; Wang D; Lin X
Immunity; 2005 Dec; 23(6):575-85. PubMed ID: 16356856
[TBL] [Abstract][Full Text] [Related]
36. CYLD is a crucial negative regulator of innate immune response in Escherichia coli pneumonia.
Lim JH; Ha UH; Woo CH; Xu H; Li JD
Cell Microbiol; 2008 Nov; 10(11):2247-56. PubMed ID: 18643924
[TBL] [Abstract][Full Text] [Related]
37. Regulation of natural killer T-cell development by deubiquitinase CYLD.
Lee AJ; Zhou X; Chang M; Hunzeker J; Bonneau RH; Zhou D; Sun SC
EMBO J; 2010 May; 29(9):1600-12. PubMed ID: 20224552
[TBL] [Abstract][Full Text] [Related]
38. Clustering of CARMA1 through SH3-GUK domain interactions is required for its activation of NF-κB signalling.
Hara H; Yokosuka T; Hirakawa H; Ishihara C; Yasukawa S; Yamazaki M; Koseki H; Yoshida H; Saito T
Nat Commun; 2015 Jan; 6():5555. PubMed ID: 25602919
[TBL] [Abstract][Full Text] [Related]
39. CYLD: a multifunctional deubiquitinase.
Glittenberg M; Ligoxygakis P
Fly (Austin); 2007; 1(6):330-2. PubMed ID: 18820455
[TBL] [Abstract][Full Text] [Related]
40. A requirement for CARMA1 in TCR-induced NF-kappa B activation.
Wang D; You Y; Case SM; McAllister-Lucas LM; Wang L; DiStefano PS; Nuñez G; Bertin J; Lin X
Nat Immunol; 2002 Sep; 3(9):830-5. PubMed ID: 12154356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
